Skip to main content

Table 1 Correlation between relative miR-106b expression and clinicopathological characteristics in HCCs (n = 104)

From: Upregulation of microRNA-106b is associated with poor prognosis in hepatocellular carcinoma

Characteristics

No. of cases

miR-106b

Pvaluea

Low

High

Age (years)

    

<50b

49

22 (44.9)

27 (55.1)

0.326

≥50

55

30 (54.5)

25 (45.5)

 

Gender

    

Female

10

3 (30.0)

7 (70.0)

0.183

Male

94

49 (52.1)

45 (47.9)

 

HBsAg

    

Negative

18

12 (66.7)

6 (33.3)

0.120

Positive

86

40 (46.5)

46 (53.5)

 

Child-Pugh

    

A

95

48 (50.5)

47 (49.5)

>0.999

B

9

4 (44.4)

5 (55.6)

 

AFP (μg/L)

    

<200c

52

30 (57.7)

22 (42.3)

0.117

≥200

52

22 (42.3)

30 (57.7)

 

Tumor size (cm)

    

<7d

50

31 (62.0)

19 (38.0)

0.019

≥7

54

21 (38.9)

33 (61.1)

 

Tumor number

    

Solitary

70

33 (47.1)

37 (52.9)

0.403

Multiple

34

19 (55.9)

15 (44.1)

 

Vascular invasion

    

Absent

82

46 (56.1)

36 (43.9)

0.016

Present

22

6 (27.3)

16 (72.7)

 

Edmondson-Steiner

    

I-II

60

34 (56.7)

26 (43.3)

0.112

III-IV

44

18 (40.9)

26 (59.1)

 

TNM stage

    

I

51

27 (52.9)

24 (47.1)

0.556

II-III

53

25 (47.2)

28 (52.8)

 
  1. aChi-square or Fisher’s exact test.
  2. b,c,dValues are median.
  3. Values in parentheses indicate percentage.
  4. Statisticaly significant values are given in bold.